VEA
SLRN

Virtus ETF Advisers’s ACELYRIN SLRN Stock Holding History

Virtus ETF Advisers’s Portfolio SLRN Stock Details SLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-20,083
Closed -$63.1K – 745
2024
Q4 		$63.1K Sell
20,083
-1,055
-5% -$5.11K 0.03% 434
2024
Q3 		$104K Buy
21,138
+375
+2% +$1.94K 0.05% 372
2024
Q2 		$91.6K Buy
20,763
+8,862
+74% +$41.5K 0.04% 352
2024
Q1 		$80.3K Sell
11,901
-816
-6% -$6.2K 0.04% 392
2023
Q4 		$94.9K Buy
+12,717
New +$109K 0.06% 383

Other funds holding SLRN

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
ACMC
AyurMaya Capital Management Company Portsmouth, New Hampshire $148M AUM 24.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return

Virtus ETF Advisers's SLRN Position: Q1 2025 in Review

Virtus ETF Advisers sold out of ACELYRIN (SLRN) in Q1 2025, closing a stake of 20,083 shares — an estimated $63.1K sold.

Virtus ETF Advisers first reported a position in SLRN in Q4 2023 and held it in 5 quarters. The position peaked at $104K in Q3 2024. 105 funds tracked by Wall St. Rank hold SLRN as of Q1 2025.

  • Virtus ETF Advisers reported no remaining ACELYRIN position as of Q1 2025 after selling out during the quarter.
  • Virtus ETF Advisers sold 20,083 ACELYRIN shares in Q1 2025, an estimated $63.1K.
  • Virtus ETF Advisers first reported a position in ACELYRIN in Q4 2023 and held it in 5 quarters.
  • Virtus ETF Advisers's ACELYRIN position peaked at $104K in Q3 2024.
  • 105 funds tracked by Wall St. Rank held ACELYRIN as of Q1 2025.

Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.